Happy New Year from Pioneer Institute

Hubwonk host Joe Selvaggi talks with Beacon Hill Institute President Dr. David Tuerck about his recent analysis of the proposed 4% surtax on incomes over $1 million in Massachusetts, and his estimate of the number of individuals who will leave the state as a result. Tuerck, an economist, used STAMP modeling tools comparing the static projections offered by proponents of the so-called "Fair Share Amendment" with a model simulation that accounts for the unintended effects of the tax.

This is no time to threaten Massachusetts’ prospects for an immediate economic recovery and the long-term competitiveness of the Commonwealth’s businesses. As Massachusetts lawmakers prepare to vote on whether to send a proposed constitutional amendment that would impose a 4 percent surtax on residents who earn $1 million or more in a year to the statewide ballot in 2022, Pioneer Institute urges them to recognize that tax policy sizably impacts business and job location decisions and that jobs are more mobile than ever.

Massachusetts’ emergency declaration for COVID-19 ends on June 15, and with it some enhanced flexibility that has been allowed in the healthcare system.  Some of the added flexibility highlighted barriers that make the system more expensive, harder to access and less patient-centered, and the Commonwealth should consider permanently removing these barriers, according to a new study published by Pioneer Institute.

This week on Hubwonk, host Joe Selvaggi talks with Suffolk University Economics Prof. Jonathan Haughton about his research into the effects and costs attending the adoption of Project Labor Agreements in large construction projects. The discussion focuses on Prof. Haughton’s two research pieces, The Effects of Project Labor Agreements in Massachusetts, and Do Project Labor Agreements Raise Construction Costs?, and the implications of PLAs on future projects in Massachusetts.

This week on “The Learning Curve," Gerard and Cara talk with Dr. Farouk El-Baz, retired research professor and director of the Center for Remote Sensing at Boston University. They discuss his remarkable, varied, and pioneering career in the sciences, surveying both the heavens and the Earth, and key teachers and scientists who have influenced him. Dr. El-Baz shares what it was like serving as supervisor of Lunar Science Planning for NASA's Apollo program, and working on the world-changing project of putting a human on the Moon.

This week on Hubwonk, host Joe Selvaggi talks with author and former New York Times science journalist Nicholas Wade about his recent article in the Bulletin of the Atomic Scientists on the possible origins of the SARS2 virus that caused the COVID-19 pandemic. In their conversation, they consider the possibility that, absent finding evidence of a natural jump from animals, the SAR2 virus may have come from a lab.

This week on “The Learning Curve," Gerard and Cara talk with Rafe Esquith, an award-winning teacher at Hobart Elementary School in Los Angeles, and the founder of The Hobart Shakespeareans, who annually stage performances of unabridged plays by William Shakespeare. He shares why he founded the award-winning program to teach disadvantaged Los Angeles elementary school students a classical humanities curriculum, the most inspiring experiences and the biggest challenges of teaching highly demanding literary works to young schoolchildren from diverse backgrounds.

The Boston-based Institute for Clinical and Economic Review (ICER) sells itself as an independent source of information on the value of pharmaceuticals. But earlier this month, their bias was again evident when they tried to kneecap a drug for a dreaded disease before there’s even enough data to determine how valuable the drug really is. ICER has adopted this same strategy in the past on innovative drugs for cancer, cystic fibrosis, and other devastating diseases. This time ICER’s target is aducanumab, Biogen’s drug for Alzheimer’s disease.